Overview: Leptospira IgM TestIntroduction: The Leptospira IgM Test detects Leptospira IgM to diagnose recent leptospirosis, causing fever or jaundice. Aligned with 2023 WHO guidelines, it uses immunoassay for high specificity, supporting parasite screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in parasitology for patients with suspected acute leptospirosis.
Other Names: Leptospira IgM Assay, Recent Leptospirosis Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: Leptospira IgM testing emerged in the 1980s with infectious disease research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Leptospira IgM to diagnose recent leptospirosis, guides treatment, and evaluates patients with fever or jaundice.
Test Parameters: 1. Leptospira IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, jaundice, or exposure to contaminated water.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, jaundice, muscle pain, or exposure to contaminated water or animals. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, leptospirosis implications, and risks of blood or saliva collection.
Procedural Considerations: Uses immunoassay to detect Leptospira IgM in serum or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for acute leptospirosis diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Early infection may yield false negatives.
Clinical Significance: Positive Leptospira IgM confirms recent leptospirosis, guiding antibiotic therapy (e.g., doxycycline). Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Leptospira PCR, IgG test, or blood-culture to confirm leptospirosis diagnosis.
Test Limitations: Early infection may yield false negatives; clinical correlation is needed. Cross-reactivity with other spirochetes may occur.
References: WHO Leptospirosis Guidelines, 2023; Clinical Infectious Diseases, Levett PN, 2022.
